Literature DB >> 7092574

Clinical experience with probucol with special emphasis on mode of action and long-term treatment.

T A Miettinen, J K Huttunen, T Kuusi, T Kumlin, S Mattila, V Naukkarinen, T Strandberg.   

Abstract

Mesh：

Substances：

Year:  1982        PMID： 7092574

Source DB:  PubMed          Journal:  Artery        ISSN： 0098-6127


× No keyword cloud information.
  3 in total

1.  Electrocardiographic effects of probucol. A controlled prospective clinical trial.

Authors:  C A Dujovne; F Atkins; B Wong; S DeCoursey; P Krehbiel; S B Chernoff
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 2.  Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia.

Authors:  M M Buckley; K L Goa; A H Price; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

3.  Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipaemic subjects.

Authors:  F Heller; C Harvengt
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.